Flattening the Risk: Pre-Exposure Prophylaxis for COVID-19.
COVID-19
SARS
coronavirus
prophylaxis
Journal
Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216
Informations de publication
Date de publication:
2020
2020
Historique:
received:
27
05
2020
accepted:
23
08
2020
entrez:
29
10
2020
pubmed:
30
10
2020
medline:
30
10
2020
Statut:
epublish
Résumé
To date, more than 35 million people worldwide have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent of coronavirus disease 2019 (COVID-19), and more than one million have died in the COVID-19 pandemic. International economies are stalled and social isolation based on palpable fear of death remains the order of the day. The United States and other countries are moving toward resuming work activities and social interaction to boost economic recovery. While this makes financial sense, from a medical perspective our population has already suffered and will continue to suffer severe losses in the absence of a viable aggressive prophylaxis strategy for SARS-CoV-2. Herein, we present a plan to address this problem.
Identifiants
pubmed: 33116688
doi: 10.2147/IDR.S264831
pii: 264831
pmc: PMC7586021
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3689-3694Informations de copyright
© 2020 Stricker and Fesler.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Chest. 2021 Jan;159(1):85-92
pubmed: 33065103
Mayo Clin Proc. 2020 Jun;95(6):1213-1221
pubmed: 32359771
Indian J Med Res. 2020 May;151(5):459-467
pubmed: 32611916
Pediatr Pulmonol. 2015 Apr;50(4):410-9
pubmed: 25491573
Lancet Glob Health. 2020 Oct;8(10):e1249-e1250
pubmed: 32828171
Clin Pharmacol Ther. 2020 Oct;108(4):766-769
pubmed: 32344449
Nature. 2020 Sep;585(7826):584-587
pubmed: 32698191
Lancet. 2006 Apr 22;367(9519):1319-27
pubmed: 16631910
Curr Pharm Des. 2004;10(25):3045-53
pubmed: 15544496
JAMA Intern Med. 2020 Oct 1;180(10):1398-1400
pubmed: 32730617
Am J Obstet Gynecol. 2016 Feb;214(2):273.e1-273.e8
pubmed: 26429521
Br J Clin Pharmacol. 1995 Aug;40(2):127-33
pubmed: 8562294
Eur Respir J. 2020 Jun 18;55(6):
pubmed: 32350103
J Med Virol. 2020 Sep;92(9):1394-1395
pubmed: 32343423
Trials. 2020 Jul 14;21(1):647
pubmed: 32665039
Clin Infect Dis. 2020 Jul 28;71(15):732-739
pubmed: 32150618
Chin Med J (Engl). 2020 May 5;133(9):1051-1056
pubmed: 32149769
EMBO Mol Med. 2020 Jun 8;12(6):e12488
pubmed: 32301279
JAMA. 2020 Jul 14;324(2):151-153
pubmed: 32496528
Transfusion. 2020 Oct;60(10):2210-2216
pubmed: 32770691
Nature. 2020 Aug;584(7821):450-456
pubmed: 32698192
N Engl J Med. 2020 Oct 29;383(18):e101
pubmed: 32897661
Ann Intern Med. 2020 Nov 3;173(9):765-767
pubmed: 32822221
Ann Intern Med. 2020 Sep 1;173(5):362-367
pubmed: 32491919
Lancet Rheumatol. 2020 Sep;2(9):e557-e564
pubmed: 32838309
J Infect. 2020 Jun;80(6):e32-e33
pubmed: 32209383
Int J Environ Res Public Health. 2020 Apr 28;17(9):
pubmed: 32353991
JMIR Mhealth Uhealth. 2016 Sep 09;4(3):e107
pubmed: 27613084
Nature. 2020 Aug;584(7821):333-334
pubmed: 32782402
BMC Infect Dis. 2021 Jan 14;21(1):72
pubmed: 33446136
Nature. 2020 Nov;587(7835):610-612
pubmed: 32998156
Open Forum Infect Dis. 2020 Oct 19;7(11):ofaa500
pubmed: 33204764
Sci China Life Sci. 2021 Feb;64(2):330-333
pubmed: 32761451
Travel Med Infect Dis. 2015 Mar-Apr;13(2):192-6
pubmed: 25825015
Am J Epidemiol. 2020 Nov 2;189(11):1218-1226
pubmed: 32458969
Travel Med Infect Dis. 2020 May - Jun;35:101738
pubmed: 32387409
Antimicrob Agents Chemother. 2009 Apr;53(4):1468-75
pubmed: 19188392
Lancet Respir Med. 2020 Oct;8(10):954-955
pubmed: 32758441
J Clin Invest. 2020 Apr 1;130(4):1545-1548
pubmed: 32167489
JAMA Cardiol. 2020 Sep 1;5(9):986-987
pubmed: 32936259
N Engl J Med. 2020 Aug 20;383(8):787-789
pubmed: 32813957
Antiviral Res. 2020 Jun;178:104787
pubmed: 32251768
Ann Rheum Dis. 2020 May;79(5):666-667
pubmed: 32241791
Lancet Rheumatol. 2020 Nov;2(11):e689-e697
pubmed: 32984847
IDCases. 2020 Apr 27;20:e00778
pubmed: 32341910
PeerJ. 2020 May 21;8:e9255
pubmed: 32509472
Nature. 2020 Oct;586(7830):516-527
pubmed: 32967006
Clin Infect Dis. 2021 Jun 1;72(11):e835-e843
pubmed: 33068425
JAMA Intern Med. 2021 Feb 1;181(2):195-202
pubmed: 33001138
JAMA. 2020 Aug 4;324(5):460-470
pubmed: 32492084
Malar J. 2018 Aug 15;17(1):295
pubmed: 30111314
Antiviral Res. 2020 Jun;178:104805
pubmed: 32330482
Cleve Clin J Med. 2018 Jun;85(6):459-467
pubmed: 29883308
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Int J Soc Psychiatry. 2020 Jun;66(4):317-320
pubmed: 32233719
Int J Antimicrob Agents. 2020 Jun;55(6):105988
pubmed: 32305587
Ann Intern Med. 2020 Nov 17;173(10):840-841
pubmed: 32783685
JAMA. 2020 Jul 14;324(2):195-197
pubmed: 32539107
Ann Clin Microbiol Antimicrob. 2020 May 30;19(1):23
pubmed: 32473642
J Med Virol. 2021 Feb;93(2):755-759
pubmed: 32644224
JAMA. 2020 Jun 2;323(21):2195-2198
pubmed: 32329797
Expert Rev Anti Infect Ther. 2021 Jan;19(1):5-16
pubmed: 32693652
Lancet. 2020 Aug 22;396(10250):535-544
pubmed: 32645347
Biosci Trends. 2020 Mar 16;14(1):1-2
pubmed: 32092748
AIDS Behav. 2020 Nov;24(11):3056-3070
pubmed: 32274670
Ann Intern Med. 2020 Oct 6;173(7):536-541
pubmed: 32589451
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238
Antiviral Res. 2020 May;177:104760
pubmed: 32135219